Vincennes, France

Francoise Lacour


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Francoise Lacour

Introduction

Francoise Lacour is a distinguished inventor based in Vincennes, France. With a remarkable portfolio of three patents, she has made significant contributions to the field of medicinal chemistry, particularly in the area of compounds used for treating metabolic disorders.

Latest Patents

Francoise Lacour's latest patents focus on ethanolamine benzoate compounds, specifically targeting the treatment of syndrome X and hypertension in insulin-resistant patients. One notable compound she developed is S-1-(m-trifluoromethylphenyl)-2-{.beta.-{4-[2-(N-(3,3-diphenylpropionyl)amino)ethyl]benzoyloxy}ethylamino} propane, which showcases innovative applications for therapeutic use. Additionally, she has patented new ethanolamine benzoate compounds that can serve as medicaments, characterized by specific formulas and their corresponding racemic compounds and enantiomers, emphasizing their potential in treating insulin-resistance states.

Career Highlights

Francoise Lacour is currently affiliated with Adir et Compagnie, a company dedicated to advancing pharmaceutical innovations. Her work has garnered attention in the medical community, particularly for its implications in treating metabolic anomalies that affect a significant portion of the population.

Collaborations

Throughout her career, Francoise has collaborated with notable colleagues such as Michel Wierzbicki and Pierre Hugon. These partnerships have enriched her research endeavors and contributed to the success of her inventions, fostering a collaborative spirit of innovation within the organization.

Conclusion

Francoise Lacour exemplifies the spirit of innovation in the pharmaceutical sector. Her extensive work with ethanolamine benzoate compounds underscores her commitment to addressing critical health issues such as insulin resistance and hypertension. As she continues to push the boundaries of medicinal chemistry, her inventions are poised to make a lasting impact on patient care and treatment modalities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…